OnabotulinumtoxinA injections for a facial muscle under-study
Part of Skin clinical trials.
This trial studies whether onabotulinumtoxinA injections are safe and work well for improving the depressor anguli oris area of the face. If you want treatment there, you may be able to join, as long as you meet the timing, skin-health, and consent requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You agree to follow the study rules and sign consent forms
- You are age 18 to 65, and if you can get pregnant, you are not currently pregnant or breastfeeding
- You are specifically looking for treatment to target the depressor anguli oris area
- You will avoid other facial cosmetic or skin procedures below the nose line during the study
- If you can get pregnant: you will use birth control during the study and do a urine pregnancy test at screening and before treatment
- You agree to allow study photography
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication's effectiveness and safety over time in adults with moderate to severe frown lines between the eyebrows. It aims to see if the treatment can reduce these lines and improve satisfaction with appearance.
This study tests whether botulinum toxin (Botox) injections can improve the appearance of drooping mouth corners. If you have mild drooping at the sides of your mouth and want to improve how it looks, this trial may help.
This trial tests an injection called HU-045 to reduce moderate to severe frown lines. It may help adults who want to soften those vertical lines between the eyebrows.
This study tests a new botulinum toxin injection (similar to Botox) to see how well it smooths moderate to severe frown lines between the eyebrows. The treatment is given as a single injection and may help soften those lines for several months.
This study tests a new medication (IPN10200) to safely reduce moderate to severe frown lines between the eyebrows in adults. It may help if you are bothered by these lines and are looking for a non-surgical option.
This study tests a new medicine (IPN10200) to see how well it works and how safe it is for reducing moderate to severe frown lines between the eyebrows in adults. If you are unhappy with the appearance of these lines, this trial may help.
Hear when a new Aging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.